Insulet
PODD
#1044
Rank
S$24.93 B
Marketcap
$355.48
Share price
9.40%
Change (1 day)
68.41%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): S$0.41 Billion

According to Insulet's latest financial reports the company's current earnings are S$1.87 Billion. In 2023 the company made an earning of S$0.33 Billion, an increase over its 2022 earnings that were of S$57.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.41 B23.71%
2023 S$0.33 B481.9%
2022 S$57.16 M-45.24%
2021 S$0.10 B43.35%
2020 S$72.81 M18.51%
2019 S$61.44 M41.16%
2018 S$43.53 M-711.95%
2017 -S$7.12 Million-56.85%
2016 -S$16.49 Million-79.31%
2015 -S$79.7 Million63.85%
2014 -S$48.65 Million31.04%
2013 -S$37.12 Million-21.96%
2012 -S$47.57 Million
2010 -S$45.37 Million-42.38%
2009 -S$78.74 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$71.42 Million209.75%
2006 -S$23.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$9.74 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.19 Billion-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.01 B 149.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.39 B 5,905.55%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.99 B 2,112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.48 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$13.46 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA